Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clinics ; 69(2): 75-82, 2/2014. tab, graf
Article in English | LILACS | ID: lil-701384

ABSTRACT

OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopause received transdermal nanostructured formulations of progesterone and estrogens in the forearm daily for 60 months to mimic the normal ovarian secretory pattern. Confocal Raman spectroscopy of hormones in skin layers was performed. Clinical parameters, serum concentrations of estradiol and follicle-stimulating hormone, blood pressure, BI-RADS classification from bilateral mammography, and symptomatic relief were compared between baseline and 60 months post-treatment. Clinicaltrials.gov: NCT02033512. RESULTS: An improvement in climacteric symptoms was reported in 92.5% of women evaluated before and after 60 months of treatment. The serum concentrations of estradiol and follicle-stimulating hormone changed significantly (p<0.05) after treatment; the values of serum follicle-stimulating hormone decreased after 60 months from 82.04±4.9 to 57.12±4.1 IU/mL. A bilateral mammography assessment of the breasts revealed normal results in all women. No adverse health-related events were attributed to this hormone replacement therapy protocol. CONCLUSION: The nanostructured formulation is safe and effective in re-establishing optimal serum levels of estradiol and follicle-stimulating hormone and relieving the symptoms of menopause. This transdermal hormone replacement therapy may alleviate climacteric symptoms in postmenopausal women. .


Subject(s)
Aged , Female , Humans , Middle Aged , Estradiol/therapeutic use , Estriol/therapeutic use , Estrogens/therapeutic use , Hormone Replacement Therapy/methods , Postmenopause/drug effects , Progesterone/therapeutic use , Administration, Cutaneous , Drug Combinations , Estradiol/blood , Follicle Stimulating Hormone/blood , Microscopy, Electron, Scanning , Particle Size , Prospective Studies , Postmenopause/physiology , Spectrum Analysis, Raman , Skin/drug effects , Time Factors , Treatment Outcome
2.
Rev. bras. farmacogn ; 22(1): 69-75, Jan.-Feb. 2012. tab
Article in English | LILACS | ID: lil-607591

ABSTRACT

The chemical composition of the essential oil obtained from the fresh and dried leaves of Lippia gracillis Schauer, Verbenaceae, was analyzed by gas chromatography and gas chromatography/mass spectrometry (GC⁄MS). The yield of essential oil extracted from the dried leaves was significantly higher (p<0.05) when compared to the fresh leaves. Seventeen components were identified. The monoterpenes and sesquiterpene hydrocarbons with 96.26 percent (w/w) of the total oil obtained of fresh leaves and 86.99 percent (w/w) of the total oil obtained of dried leaves were the principal compound groups. Thymol was observed dominant (44.42 percent; 21.3 percent), followed by carvacrol (22.21 percent; 21.30 percent), p-cymene (6.23 percent; 8.58 percent), α-pinene (5.65 percent; 19.42 percent), β-caryophyllene (5.61 percent; 3.57 percent) and other minor constitutes, respectively. Microbiological results obtained by agar diffusion method, micro dilution method and minimum inhibitory concentration (MIC) showed that the essential oil has a relevant antimicrobial activity against E. coli (ATCC 10536), E. coli (Ec 27), Pseudomonas aeruginosa (ATCC 15442), S. aureus (ATCC 12692) and S. aureus (Sa 358), with their inhibition zones ranging from 9 to 13 mm and the MIC ranging from 64 to 512 μg/mL.

3.
J. appl. oral sci ; 18(4): 335-342, July-Aug. 2010. ilus, graf
Article in English | LILACS | ID: lil-557101

ABSTRACT

OBJECTIVES: The aim of this study was to test the efficacy of a locally applied 8.5 percent nanostructured doxycycline (DOX) gel in preventing alveolar bone loss in experimental periodontal disease (EPD) in rats by using the tapping mode atomic force microscopy (AFM). MATERIAL AND METHODS: EPD was induced in 24 Wistar rats. Animals were treated with the doxycycline gel topically, immediately after EPD induction, and 3 times a day during 11 days. Four groups (n=6) were formed as follows: Naïve group (animals not subjected to EPD nor treated); non-treated (NT) group (animals subjected to EPD, but not treated); vehicle gel (VG) group (animals subjected to EPD and treated with topical gel vehicle); and DOX group (test group): animals subjected to EPD and treated with the 8.5 percent DOX gel. In order to investigate topographical changes in histological sections, a novel simple method was used for sample preparation, by etching sections from paraffin-embedded specimens with xylol. RESULTS: Comparing the AFM images, several grooves were observed on the surface of the alveolar bone and other periodontal structures in the NT and VG groups, with significantly greater depths when compared to the DOX group (p<0.05). CONCLUSIONS: Periodontal structures were brought into high relief confirming to be a simple and cost-effective method for AFM imaging with ultrastructural resolution. The doxycycline gel was able to afford periodontal surface preservation, with flatter grooves.


Subject(s)
Animals , Male , Rats , Alveolar Bone Loss/prevention & control , Anti-Bacterial Agents/administration & dosage , Drug Delivery Systems , Doxycycline/administration & dosage , Nanospheres/administration & dosage , Periodontitis/etiology , Administration, Topical , Alveolar Bone Loss/pathology , Alveolar Process/pathology , Dental Cementum/pathology , Gels , Gingiva/pathology , Image Processing, Computer-Assisted , Microscopy, Atomic Force , Nanotechnology , Neutrophils/pathology , Periodontal Ligament/pathology , Periodontitis/pathology , Peroxidase/analysis , Random Allocation , Rats, Wistar , Time Factors , Tooth Root/pathology
4.
RPG rev. pos-grad ; 8(1): 70-75, jan.-mar. 2001. tab, graf
Article in Portuguese | LILACS, BBO | ID: lil-312783

ABSTRACT

No presente trabalho investigou-se a prevalência de bruxismo em 277 pacientes sintomáticos, com idades variando entre 8 e 73 anos. Avaliaram-se os aspectos etiológicos que poderiam estar envolvidos, como condiçäo psicológica, saúde geral e padräo oclusal de cada paciente. As mulheres predominam em todas as faixas etárias, numa proporçäo maior que 3:1. A faixa etária com maior número de pacientes foi a compreendida entre 26 e 40 anos. Observou-se que o fator psíquico interferiu significativamente nas faixas etárias compreendidas entre 26 e 40 anos e 41 e 73 anos. O fator oclusal estava envolvido na etiologia de 100 por cento dos casos, visto que apenas dois pacientes encontravam-se em relaçäo de oclusäo cêntrica, porém desprovidos de guias incisais e guias de canino. O bruxismo, associado ou näo a outra desordem temporomandibular, teve incidência de 61,8 por cento nos pacientes do sexo masculino, contra a incidência de 62,7 por cento no sexo feminino


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Bruxism , Temporomandibular Joint Disorders , Age Distribution , Bruxism , Prevalence , Sex Distribution
SELECTION OF CITATIONS
SEARCH DETAIL